BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 19, 2011
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Parsortix preclinical data

In vitro, the Parsortix cancer cell separation device was able to capture cultured prostate cancer cells that were added to blood. The device has previously been shown to capture breast cancer cells that were added to blood. Earlier...

Read the full 167 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >